An alternatively spliced zebrafish jnk1a transcript has an essential and non-redundant 1 role in development of the first heart field derived proximal ventricular chamber.
with sub-functionalisation and different expression patterns. For example, there is only one 108 persisting functional gene for jnk2 and jnk3, but jnk1 remains duplicated as jnk1a and jnk1b. 109
110
In this study we have uncovered the role of jnk1 in heart development using zebrafish to 111 overcome embryonic death which has limited mouse studies. These studies show 112 developmental stage and tissue level changes in jnk1 transcripts brought about by 113 differential gene expression and alternative splicing. Using both CRISPR null mutants and 114 morpholinos we show a specific requirement for jnk1a in development of the FHF-derived 115 ventricle; the evolutionary equivalent of the left ventricle in man. Moreover, we show that 116 only one specific evolutionarily conserved alternative splice transcript is responsible for this 117 role and that its production is associated only with jnk1a, as a result of sub-specialisation. We used the zebrafish to understand the developmental roles of jnk genes in vertebrate 125 cardiac morphogenesis. Initial bioinformatic analysis of the zebrafish genome using Ensembl 126 (assembly GRCz11) [26] indicated that the zebrafish jnk1a and jnk1b genes are paralogs 127 and orthologs of human JNK1 (Figure 1A, B ). Expression studies in mice [19, 20] show that 128
Jnk2 is widely and strongly expressed throughout the developing embryo and Jnk3 is 129 reported to be expressed in the heart. Before concentrating on jnk1 function we examined 130 the expression of jnk2 and jnk3 in embryonic development. We noted a similar broad 131 expression pattern of jnk2 in developing zebrafish as described in mouse ( Figure 1C ). 132
Expression of jnk3 was limited to the developing central nervous system at 24 hours post 133 fertilisation (hpf) and we were not able to show jnk3 expression in the developing zebrafish 134 heart by wholemount in-situ hybridisation (WISH) ( Figure 1C ). These findings were 135 confirmed by RT-PCR of extracted hearts, with jnk3 transcripts clearly detected at 48 hpf but 136 only weak expression of jnk3 detected at 24 hpf. jnk2 was detected at both time points 137 ( Figure 1D ). We therefore focussed our attention on jnk1a and jnk1b expression and in 138 particular wanted to look at expression of alternatively spliced transcript variants 139
Expression of jnk1 has been reported in zebrafish [27] but at that time the gene duplication 140 was not recognised, and the presence of alternative spliced transcripts not attempted. In 141 order to examine the spatial-temporal expression of these jnk1 paralogues, we firstly sub-142 cloned jnk1a and jnk1b transcripts from pooled whole embryos at 24, 48 and 72 hpf and 143 analysed their sequence, revealing conservation of the alternative splicing patterns seen in 144 human JNK1. Each gene revealed four transcript variants indicating alternative exon 7/8 145 usage and an alternative splice re-entry site encoding short (Sh) and long (Lg) C-terminal 146 peptides ( Figure 1E and sequences in Supplementary Table 2 ). The splicing events required 147 to produce these transcripts correspond to exon 6a/6b alternative splicing and the p46 or 148 p54 C-terminal extension variants of human JNK1 [11] . Comparison of the predicted 149 zebrafish jnk1a/jnk1b peptides with human JNK1 peptides [28] suggested the potential for 150 sub-functionalisation. The zebrafish jnk1a gene, but not the jnk1b, was capable of producing 151
Ex7 Lg and Ex7 Sh products, equivalent to human JNK1 Ex6a p46 and p54 C-terminal 152 extension variants. In complementary fashion, jnk1b appeared capable of producing an Ex8 153
Sh peptide comparable with the human JNK1 Ex6b p46 variant. However, neither jnk1 154 zebrafish gene produced a product typical of the human JNK1 Ex6b p54 splice variant. 155
Specifically, the exon 8 peptide of the zebrafish jnk1a was not well conserved in comparison 156 with human JNK1 exon 6b peptide and, although the jnk1b Ex8 peptide was conserved, the 157 C-terminal peptide extension provided by jnk1b was extremely divergent from the human C-158 terminal extension ( Figure 1F ). 159 160
Specific jnk1a splice variants may play a role in early ventricular morphogenesis 161
To understand the implications of the jnk1a-jnk1b gene duplication event we attempted a 162 spatiotemporal analysis of all eight transcripts by WISH. Riboprobes based on the full-length 163 transcripts were used in high-stringency conditions. As expected, high levels of jnk1a and 164 jnk1b transcripts were expressed throughout the developing brain. Despite the degree of 165 similarity between each of the gene products, it was possible to identify different expression 166 patterns corresponding to the different transcripts, particularly in the developing heart ( Figure  167 2A and Supplementary Figure 1 ). At 24 hpf: jnk1a Ex8 Lg; jnk1b Ex8 Sh; and jnk1b Ex8 Lg 168
were expressed in the heart as well as throughout the developing head structures (Figure 2 169 B-D). One specific jnk1a splice variant, jnk1a Ex7 Lg, was strongly and specifically 170 expressed solely in the developing heart at 24 hpf ( Figure 2A ). By 48 hpf this transcript was 171 clearly localised to the proximal, rather than distal, part of the developing ventricular 172 chamber, with some localised expression in the adjacent part of the developing atrium. 173 174
Expression profile of jnk transcripts different between heart and whole embryo 175
To confirm this expression and provide quantitative data, we designed a semi-quantitative 176 RT-PCR/restriction enzyme assay to measure the relative expression of the individual jnk1a 177 and jnk1b alternatively spliced transcripts ( Figure 2E ). This was based on RT-PCR to identify 178 exon 7/8 usage and then a restriction digest to determine the fraction of each PCR product 179 relating to short or long C-terminal extension ( Figure 2B and Supplementary Figure 2 for 180 validation of assay) [29] . Between fertilisation and the onset of gastrulation, 80% of jnk1 181 transcripts originated from the jnk1a gene. However, after this jnk1b transcripts became 182 increasingly abundant and by 120 hpf, 80% of jnk1 transcript originated from jnk1b ( Figure  183 2F). Throughout this phase of development, the majority of jnk1a transcripts encoded for the 184 long C-terminal form with equal representation of exons 7 and 8 containing transcripts 185 ( Figure 2G ). In contrast, the majority of jnk1b transcripts contained exon 8 and were of the 186 short C-terminal form. These data are dominated by the forming brain and somites as major 187 sites of jnk1 expression in the early embryo. To understand which transcripts are specifically 188 important in heart development we isolated whole hearts [31] at key embryonic stages. The 189 transcript assay was performed on hearts extracted at 32 hpf, when the linear heart tube has 190 formed from first heart field (FHF) precursors, but before significant addition of the second 191 heart field (SHF) cells [23, 32] . This was compared with 48 hpf and 72 hpf, timepoints when 192 addition of the second heart field is complete [23, 32] . The proportion of transcripts 193 represented by the jnk1a gene within the heart paralleled the changes observed in the whole 194 embryo, with falling levels of jnk1a ex7 Lg, and lower, but maintained, levels of jnk1a ex8 Lg 195 ( Figure 2H ). In contrast, whilst jnk1b Ex8 Sh had become the most abundant transcript in the 196 entire embryo, its levels gradually fell within the heart and by 72 hpf, jnk1b Ex7 Sh was the 197 most abundant transcript. 198
jnk1a and jnk1b mutants appear overtly normal 200
To understand the functions of jnk1 in heart development we designed translation-blocking 201 morpholino oligonucleotides to knock down production of jnk1a and jnk1b protein and 202 created jnk1a and jnk1b null mutants using CRISPR-Cas9 (Figure 3 A, B ). Although jnk1a 203 morphants appeared normal, approximately 50% of jnk1b morphants exhibited curling of the 204 tail and a similar percentage of jnk1a/jnk1b morphants exhibited minor pericardial oedema. 205
Experiments were carried out using 1ng jnk1b MO and 2ng jnk1a MO as these were the 206 minimal dosages that produced the abnormalities later identified in the mutant lines (see 207 below), without any evidence of off target effects. For the mutants, after initial outcrossing, 208 heterozygotes were in-crossed and resulted in zygotic (Z) null mutants that were fertile and 209 of normal appearance. These could then be in-crossed and maintained as homozygous 210 maternal zygotic (MZ) null lines, where eggs contained no maternally deposited jnk mRNA. 211
Null mutations were confirmed both by sequencing genomic DNA ( Figure 3A 
Hypoplastic first heart field ventricular segment 217
The highly specific expression pattern of jnk1a Ex7 Lg (Figure 2A Immunolabeling of the heart chambers at that time indicated that the ventricular chamber 223 was reduced in size in MZjnk1a mutants and 2ng jnk1a morphants at 28 hpf. However, there 224 was no apparent change in MZjnk1b mutants and jnk1b morphants and furthermore no 225 additional size reduction in MZjnk1a/MZjnk1b double mutants ( Figure 4A ). 226
The first morphological evidence of left-right asymmetrical remodelling in vertebrates is 227 manifest as jogging of the heart tube. In most normal zebrafish embryos, the heart tube 228 extends from the midline towards the left side of the body, whereas in 1-2% of wildtype 229 embryos this jogging is reversed or hearts lie in the midline. Then, looping of the heart tube 230 places the atrium to the left side of the ventricle but again, in 1-2% of normal embryos this is 231 reversed, or the chambers remain orientated in the midline. In the MZjnk1a, MZjnk1b, 232
MZjnk1a/MZjnk1b mutants and jnk1a morphants, there was no significant difference in 233 looping disturbance at 48 hpf ( Figure 4B ). However, a small degree of jogging and looping 234 disturbance was noted in jnk1b morphants at the same stage; further analyses regarding the 235 role of jnk in left-right patterning is described elsewhere (Santos-Ledo et al; in preparation). 236
Following formation of the initial heart tube and concomitant with asymmetrical remodelling is 237 the continued addition of SHF cells to the heart tube. In birds and mammals with septated 238 hearts SHF cells form the right ventricle, but in the zebrafish, which maintains a single 239 unseptated ventricle, the SHF cells add to the distal part of the common ventricle [23, 24, 32] . 240
To fully assess the size of the FHF and SHF atrial ventricular components we counted the 241 number of atrial and ventricular cardiomyocytes within the heart at 28 hpf, when the FHF 242 cells have added but the SHF cells have not, and at 56 hpf when the SHF accretion is of MZjnk1a mutants at the same stages indicated a 26% reduction in ventricular 249 cardiomyocytes at 28 hpf. There was no significant reduction in MZjnk1b mutants and no 250 additional reduction in MZjnk1a/MZjnk1b compared to MZjnk1a mutants ( Figure 4E ). To 251 confirm that there was normal addition of SHF progenitors to the heart tube we used a 252 zebrafish line expressing the photoconvertible kikGR reporter under the control of the myh7 253 promoter [23]. Photo-conversion of kikGR at 20 hpf identifies FHF cardiomyocytes, in which 254 the myh7 promoter is already active, and allows them to be distinguished from SHF CMCs 255 that only later activate the myh7 promoter and thus only exhibit non-photoconverted protein 256
[23]. Analysis at 50 hpf showed that here was no difference between jnk1a morpholino 257 treated embryos and controls (Figure 4 
F,G). 258
We asked if there might be functional consequences from this significant and localised 259 deficiency of FHF ventricular cardiomyocytes. We therefore examined heart function at 72 260 hpf in control and MZjnk1a mutant embryos. Using video microscopy it was evident that the 261 FHF ventricular component, adjacent to the atrioventricular valve, was of reduced size and 262 hypokinetic in the MZjnk1a mutant compared with their control counterparts ( Figure 4H ) 263 leading to a reduction in ventricular fractional shortening ( Figure 4I ). There was also a 264 reduction in heart rate in the mutant embryos ( Figure 4J ). 265
266
In order to confirm that the defects in formation of the FHF ventricular component were 267 specific to jnk1a knockdown, and to establish whether they related specifically to any of the 268 isoforms, the four jnk1a transcripts: Ex7 Sh; Ex7 Lg; Ex8 Sh; and Ex8 Lg were evaluated 269 with regard to their ability to rescue the ventricular cardiomyocyte deficit at 28 hpf ( Figure  270 4H). One cell-stage embryos were injected simultaneously with the jnk1a morpholino and 271 100pg capped mRNA corresponding to the individual transcripts. Only the jnk1a Ex7 Lg 272 transcript was able to fully rescue the FHF cardiomyocyte deficit and the effect was still 273 evident at 56 hpf ( Figure 4I ). None of the other three jnk1a transcripts, separately or in 274 combination, were able to do this. These data suggest that jnk1a Ex7 Lg is specifically 275 required to produce the normal FHF derived ventricular component, the equivalent of the left 276 ventricle in septated hearts. 277
278

Mechanism of FHF ventricular cardiomyocyte deficiency 279
To understand how disruption of jnk1a function might lead to this specific deficiency of FHF 280 ventricular cardiomyocytes, we followed the development of cardiomyocytes from their 281 appearance in the anterior lateral plate mesoderm (ALPM) to their coalescence to the 282 primary heart tube. At the 8-somite stage (ss) cells in the parasagittal ALPM express the key 283 transcriptional regulators nkx2.5, hand2 and gata5. In jnk1a morphants the expression 284 patterns of these genes all appeared normal ( Figure 5A ). Whilst the expression pattern of 285 these genes includes other non-cardiomyocyte cells, ventricular cardiomyocytes could be 286 specifically detected by ventricular specific myosin (myh7) expression at 15ss ( Figure 5B ). At 287 this point there was no difference between the expression patterns of jnk1a morphants and 288 controls. However, at 18ss the expression pattern of myh7 revealed midline convergence of 289 ventricular cardiomyocytes occurring in control embryos, but not jnk1a morphants. 290
Subsequently, at 22ss, there was incomplete formation of the cardiac cone in the morphants, 291 and at 24 hpf the heart tube appeared poorly extended ( Figure 5B ). To exclude 292 developmental delay as a cause of the failure to form the heart cone in the jnk1a morphants, 293
we immunolabelled the forming trunk myotomes with MF20 antibody between 16 and 30 hpf. 294
This demonstrated no difference in the number of myotomes in jnk1a morphants when 295 compared with control embryos when assessed at 14ss (13 hpf), 18ss (17 hpf) or at 30hpf. 296 ( Figure 5C ). The MF20 antibody also labelled cardiomyocytes and demonstrated a failure of 297 cardiomyocytes to migrate from the lateral plate mesoderm to midline in jnk1a morphants. 298 ( Figure 5D ). During their migration from the ALPM to the midline, cardiomyocytes undergo 299 cell division. To identify cell that are proliferating during this phase we carried out BrdU 300 pulsing at 16ss in myl7:kikGR embryos treated with jnk1a morpholino or mismatch control 301 morpholino and assayed for incorporation at 28hpf. There was no difference in proliferative 302 activity between cardiomyocytes from jnk1a morphants and controls ( Figure 5E ). Similarly, 303
using myl7:kikGR in combination with acridine orange, there was no evidence of increased 304 programmed cell or necrotic death within the heart between the morphants and the control 305 embryos ( Figure 5F ). 306
To evaluate this abnormal cardiomyocyte migration behaviour in more detail, we carried out 307 time-lapse confocal imaging of cardiomyocytes labelled with myl7:gfp between the 16ss and 308 20ss as they migrated from the ALPM to the midline and coalesce to form the heart cone. 309
Close examination revealed that the migration of cardiomyocytes to the heart cone was 310 disturbed. Tracking individual CMCs indicated the mean velocity of cells as they migrated to 311 the heart cone was reduced in jnk1a morphants ( Figure 6D ) and this was because the 312 cardiomyocytes took a more wandering path ( Figure 6E ). These abnormal behaviours were 313 improved by co-injection of jnk1a Ex7 Lg mRNA, increasing their velocity ( Figure 6D ) and 314 normalising the directional component of migration ( Figure 6E ). 315 316 317
Discussion 318
Our understanding of heart morphogenesis and the developmental basis of congenital heart 319 malformations is now underpinned by the concept of the first and second heart fields. The 320 addition of SHF progenitors to the FHF-derived heart tube provides cardiac structures 321 required for breathing air (i.e. the septated heart with a pulmonary circulation), but the 322 presence of the SHF in zebrafish is proof that the SHF predates the evolutionary emergence 323 of these structures [23, 24, 30, 33] . 324
325
In this study we have found that a reduction in the FHF cardiomyocyte contribution to the 326 zebrafish ventricle occurs when jnk1a gene expression is abrogated and that the reduction is 327 completely and specifically rescued by the highly conserved jnk1a Ex7 Lg alternative spliced 328 transcript. Whilst the same findings in both jnk1a morphants and MZ null mutants, together 329 with the highly specific mRNA rescue are compelling, suggesting that Jnk1a plays a 330 fundamental role in FHF cardiogenesis, Jnk1 null mouse embryos are not reported to have a 331 cardiac phenotype [18, 19] . However, close examination of published images indicates that 332 Jnk1/Jnk2 null (double mutant) mouse embryos harvested at E11.5 appear to have ceased 333 development at E9.5, and to have a hypoplastic ventricle [19] . Detailed re-analysis of the 334 Jnk1, and ideally Jnk1/Jnk2 double null mouse embryos will be important to clarify this. 335
Despite the lack of compensation from SHF cardiomyocytes, the reduction in the FHF-336 derived ventricular component is well tolerated by the MZjnk1a mutants. This is probably 337 because the FHF and SHF addition add to the same chamber in fish. Notably, however, the 338 deficiency can still be observed at 72 hpf by akinesia of the FHF-derived segment of the 339 ventricle and reduced heart rate, which has been shown to be due to disturbed coupling 340 between the heart field components [24] . In vertebrates with a septated heart, this 25% 341 reduction in cardiomyocytes would be expected to be clinically apparent, as a hypoplastic 342 left ventricle. for a more profound reduction in cardiomyocyte numbers. We can say, however, that there is 376 no compensation from jnk1b transcripts as there was no additional reduction in 377 cardiomyocytes in MZjnk1a/MZjnk1b mutants, and a greater reduction in cardiomyocytes 378 was seen in jnk1a mutants (25%) than morphants (15%). reports where specific splice variants have been shown to play a discrete mechanistic role 405 during embryogenesis that is unique to that transcript and not shared with other related 406 transcripts. There is tantalising circumstantial evidence in the literature to support the idea 407 that individual transcripts may be specifically activated by different gene networks, for 408 example the phosphatase DUSP8 preferentially inactivates exon 6a-containing (equivalent 409 of Ex7 in zebrafish) JNK1 peptides [53] . In this study we have comprehensively shown 410 developmental and organ specific splicing changes within the duplicated and highly 411 conserved gene jnk1. Importantly, we have shown the balance of Ex7 and Ex8 expression in 412 developing embryos is not random, as has been suggested previously [11] . Furthermore, we 413 have shown that there is a functional interaction between central exon usage and C-terminal Null mutant jnk1a and jnk1b zebrafish were made using CRISPR-Cas9-mediated 443 mutagenesis [56] in the AB wildtype line with guide RNA identified using CRISPRscan [57] . 444
Screening and subsequent genotyping was carried out by demonstrating disruption of a 445 specific restriction site (jnk1a: EcorV and jnk1b: MwoI; see Supplementary Table 1) . 446
Mutations were confirmed by sequencing and outcrossing of lines. 447 448
Cloning of alternatively spliced transcripts 449
Embryos at 24-72 hpf were pooled and RNA extracted using Trizol (Life Technologies) 450 permitting generation of cDNA using Superscript III and oligo-dT primers. Alternatively 451 spliced transcripts were identified by sub-cloning and sequencing of colonies (see 452
Supplementary Table 1 for primer sequences). Transcripts for use in morpholino rescue 453 experiments were produced using degenerate primers with at least 5 mismatches respect to 454 the original cDNA (see Supplementary Table 1 ) and expressed using the zebrafish Gateway Figure 2) . 466
Primers are indicated in Supplementary Table 1 . Products were visualised on a 2% agarose 467 gel and gel densitometry carried out using Fiji [60] . Aliquots of each PCR product were 468 purified by ethanol and sodium acetate precipitation and resuspended in 10µl of nuclease-469 free water prior to restriction enzyme digestion. Digestion for 1 hour at 37° was carried out 470
with StyI-HF (jnk1a) and NheI-HF (jnk1b) and gel densitometry performed. These values 471 were normalized against the ef1α value and with regard to the efficiency of the PCR reaction 472 as established with plasmids containing full length transcripts ( Supplementary Figure 2) . 473 474
Wholemount in-situ hybridisation 475
Full-length jnk1a and jnk1b alternatively spliced transcripts were used to generate 476 riboprobes. For jnk2 and jnk3 an 1100 amplicon was selected. In addition: hand2, nkx2. AlexaFluor-568 anti-rabbit (1/300; A10042, Invitrogen), AlexaFluor-568 anti-rat (1/300; 490 A11077, Invitrogen). Nuclei were counterstained with DAPI (1:10,000; D9542, Sigma). 491 492
Cardiomyocyte quantification 493
Cardiomyocyte nuclei were identified by immunolabelling with Mef2 antibody at 28 hpf [33] 494 and the myh7:DsNucRed transgene at 52 hpf [32] . Atrial cardiomyocytes were identified by 495 co-labelling with S46 antibody. Positioning under a glass coverslip allowed all cardiomyocyte 496 nuclei to be imaged in the same focal plane and manual counting was performed using Fiji 497
[60]. To differentiate the first heart field cardiomyocyte complement from the second heart 498 field accretion we used we used myh7:kikGR transgenic line injected with either mismatch 499 control or jnk1a morpholino. Embryos were exposed to UV light at 20hpf, photoconverting all 500 cardiomyocytes already expressing kikGR from green to red emitting forms. Imaging and 501 quantification were performed as before. 
Cell death 519
Embryos from the myh7:kikgr line were injected with either control or jnk1a morpholino and 520 incubated in 10µg/ml of acridine orange during the phase of migration from ALPM to the 521 cardiac cone. As acridine orange is visualised in the FITC fluorescent channel, 522 photoconversion of kikGR in FHF cardiomyocytes allowed identification of cardiomyocyte 523 nuclei using the TRITC channel. As above, acridine orange positive cardiomyocytes were 524 quantified using Fiji [60] . 
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Translation blocking jnk1a MO Crispr Cas9 mutant VTRYYRAPEVILGMGCGHLVCGLHFGRNGPSQNPFSWEGLY* Peptide 1 2 3 4 5 6 7 8 9 10 11 12 13
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Cripsr gRNA . Amino acids coded by exon 7 within jnk1a match those in human exon 6a, but jnk1b lacks a conserved serine residue (*). In reciprocal fashion, exon 8 in jnk1b encodes a conserved threonine residue seen in JNK1 exon 6b, whilst jnk1a codes for serine in exon 8 (**). The short C-terminal peptide sequence was completely conserved between the species. The C-terminal extension seen in jnk1a was almost identical to the human, but the jnk1b extension differed by 9/39 amino acids including insertion of an additional threonine residue. approximately 50% of jnk1b 1ng morphant displays tail curling (*) and some jnk1a 2ng/jnk1b 1ng morphants additionally display mild pericardial oedema (arrow). ventricular cardiomyocytes are labelled by MF20 antibody (red) and atrial cells by both MF20 and S46 antibody (appear yellow). Normal appearances seen in embryos exposed to 2ng mismatch morpholino (mmMO). Ventricular hypoplasia (shown by size of white bar) is seen in embryos injected with 2ng jnk1a morpholino, but not in those treated with 1ng jnk1b morpholino. Maternal zygotic (MZ) jnk1a null mutants have a comparable degree of ventricular hypoplasia, which is not seen in MZjnk1b. There is no additional ventricular hypoplasia in MZjnk1a/MZjnk1b double mutants. (B) Minimal levels of disordered cardiac looping in MZjnk1a and MZjnk1b mutants, alone and in combination. There is no increase in cardiac looping abnormalities in jnk1a 2ng MO treated embryos.
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(C) Quantification of cardiomyocytes within the developing heart. Embryos at 28 hpf treated with 2ng mmMO or 2ng jnk1a MO immunolabelled with mef2 antibody which identifies all cardiomyocyte nuclei at this stage, and S46 antibody which identifies atrial cells. Hypoplasia of the FHF-derived ventricular segment is obvious at 28 hpf (line). (D,E) In embryos treated with 2ng jnk1a MO there is a reduction in ventricular cardiomyocytes at 28 hpf before, and at 52 hpf after, completion of the SHF cardiomyocyte accretion. Although there are increased numbers of cardiomyocytes at 56 hpf, this difference remains. There is no change in the numbers of atrial cardiomyocytes. The same reduction in FHF-derived ventricular cardiomyocytes is seen in MZjnk1a mutants at 28 hpf but not in MZjnk1b mutants and there is no change in severity of this phenotype when jnk1a and jnk1b are both absent. 
